Catalyst Fellowships launched to support talented child health researchers

14 Dec 2017, 4:32 p.m.

Research in lab

The Catalyst Fellowships are an exciting new initiative supported by the National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre aiming to build the capacity of child health researchers and enabling them to become the research leaders of the future.The fellowship, which provides up to 18 months of salary support, will help talented individuals take the next step towards establishing themselves as independent researchers. Applications are invited from clinical and non-clinical trainees.

The Catalyst Fellowships have been spearheaded by the recently-established GOSH BRC Junior Faculty, a group that aims to support the career development of junior researchers.

This new fellowship is a reflection of the importance that GOSH and ICH place on nurturing the next generation of paediatric researchers. This funding will support junior researchers in making the transition to senior leaders and allow them to develop their careers within the world-class research environment of GOSH and ICH.

The deadline for applications is Thursday 1st March 2018.

Application form and eligibility criteria (0 bytes)

Enquiries: brc@gosh.nhs.uk

Young people donate tissue samples to unlock mysteries of arthritis

A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS

A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.

Genes may help to predict which children will respond well to arthritis treatment

A team of researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have identified a set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis.

Making it easier to invest in frontline care

GOSH and UCL have signed a landmark agreement to simplify the commercialisation of any joint research and innovation and ensure any financial proceeds are shared equally.